Stella Cooremans Pena
Family · Boerne, TXNPI 1790157758
Payments from drug & device makers
Across 444 payments — averaging $22.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$2K
- Johnson & Johnson$1K
- UCB, Inc.$845
- Lilly USA, LLC$785
- Mallinckrodt Hospital Products Inc.$767
- Novartis$756
- plus $3K from 21 others
What the payments were for
- Food & beverage$9,90699%
- Education$1141%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 109 | $2,110 |
| Johnson & Johnson | 59 | $1,361 |
| UCB, Inc. | 25 | $845 |
| Lilly USA, LLC | 29 | $785 |
| Mallinckrodt Hospital Products Inc. | 33 | $767 |
| Novartis | 34 | $756 |
| GSK | 23 | $611 |
| AstraZeneca(2 entities) | 27 | $519 |
| Genentech USA, Inc. | 27 | $459 |
| AbbVie | 5 | $424 |
| Pfizer | 23 | $381 |
| Boston Scientific | 10 | $172 |
| Pacira Therapeutics, Inc. | 6 | $160 |
| Fresenius Kabi USA, LLC | 5 | $139 |
| E.r. Squibb & Sons, L.L.C. | 5 | $98 |
| Ferring Pharmaceuticals Inc. | 6 | $95 |
| Organon | 4 | $74 |
| Radius Health, Inc. | 3 | $70 |
| Celltrion USA Inc. | 2 | $43 |
| Actelion Pharmaceuticals US, Inc. | 2 | $29 |
| Boehringer Ingelheim | 1 | $21 |
| Sanofi | 1 | $20 |
| Aurinia Pharma U.S., Inc. | 1 | $19 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $17 |
| Hikma Pharmaceuticals USA | 1 | $16 |
| ANI Pharmaceuticals, Inc. | 1 | $15 |
| Cumberland Pharmaceuticals, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$10,020 in reported general payments places this provider in the 95th percentile of 15,456 family providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira(Cf) PenAdalimumab | 22 | $196,722 |
| Enbrel SureclickEtanercept | 19 | $164,108 |
| Mycophenolate Mofetil | 20 | $5,967 |
| Hydroxychloroquine Sulfate | 125 | $5,731 |
| Leflunomide | 52 | $3,503 |
| Duloxetine Hcl | 62 | $2,001 |
| MethotrexateMethotrexate Sodium | 97 | $1,981 |
| Gabapentin | 48 | $1,863 |
| Sulfasalazine DrSulfasalazine | 37 | $1,748 |
| Cevimeline Hcl | 11 | $1,238 |
| Colchicine | 11 | $968 |
| Azathioprine | 19 | $683 |
| Pregabalin | 19 | $498 |
| Sulfasalazine | 23 | $475 |
| Celecoxib | 17 | $360 |
Paid to pharmacies, not to this prescriber.
Other family in Boerne
- Lashonda CraneHouston$3.4M
- David WeirDallas$959K
- Luba YammineHouston$479K
- Robin BeachHouston$428K
- Nirupama JeromeAustin$418K
- April LopezMcAllen$417K
- Linda MercadoHouston$211K
- Sarah AguilarHouston$199K
- Sie ThomasDallas$197K
- Anna CastroSan Antonio$184K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.